Sodium thiosulfate (STS) can be used to prevent cisplatin-induced ototoxicity in children and adolescents with cancer, according to a recent clinical-practice guideline.

Cisplatin-induced ototoxicity is permanent and progressive, and while a clinical-practice guideline is available for ototoxicity surveillance, advice is lacking for interventions to reduce ototoxicity in pediatric oncology, the developers say.